Pacific Biosciences of California, Inc. (PACB) Social Stream



Pacific Biosciences of California, Inc. (PACB): $24.39

-0.16 (-0.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Pacific Biosciences Of California Inc (PACB) Price Targets From Analysts

Use the tables below to see what analysts covering Pacific Biosciences Of California Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $62 $30 $45.75 $24.55 86.35%

The Trend in the Analyst Price Target


Over the past 39 weeks, PACB's average price target has gone up $28.35.

PACB reports an average of 35.55% for its upside potential over the past 17 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 4 62 30 45.75 27.990 63.45%
2021-09-19 4 62 30 45.75 29.440 55.4%
2021-09-18 4 62 30 45.75 29.440 55.4%
2021-09-11 5 62 30 47.00 29.850 57.45%
2021-09-04 5 62 30 47.00 31.230 50.5%
2021-08-28 5 62 30 47.00 30.080 56.25%
2021-08-14 5 62 30 47.00 29.470 59.48%
2021-08-07 5 62 30 47.00 32.310 45.47%
2021-08-05 5 62 30 47.00 35.020 34.21%
2021-08-01 4 62 30 47.25 32.150 46.97%
2021-07-24 4 62 30 47.25 30.350 55.68%
2021-07-17 4 62 30 47.25 26.480 78.44%
2021-07-10 4 62 30 47.25 31.960 47.84%
2021-07-03 4 62 30 47.25 33.480 41.13%
2021-06-26 4 62 45 51.50 33.810 52.32%
2021-06-13 4 62 45 51.50 29.220 76.25%
2021-06-05 4 62 45 51.50 26.120 97.17%
2021-05-22 4 62 45 51.50 25.570 101.41%
2021-05-15 4 62 45 51.50 23.560 118.59%
2021-05-08 4 62 45 51.50 24.890 106.91%
2021-04-25 4 62 45 51.50 30.960 66.34%
2021-04-17 4 62 45 51.50 31.530 63.34%
2021-04-10 4 62 45 51.50 32.160 60.14%
2021-04-03 4 62 45 51.50 33.820 52.28%
2021-03-20 4 62 45 51.50 33.430 54.05%
2021-03-13 4 62 45 51.50 33.890 51.96%
2021-03-06 4 62 45 51.50 29.270 75.95%
2021-02-27 4 62 45 51.50 30.570 68.47%
2021-02-20 4 52 45 47.25 43.030 9.81%
2021-02-13 4 52 45 47.25 50.320 -6.1%
2021-02-06 4 45 12 24.25 36.220 -33.05%
2021-01-30 4 45 12 24.25 32.350 -25.04%
2021-01-23 4 45 12 24.25 37.420 -35.2%
2021-01-16 4 45 12 24.25 36.925 -34.33%
2021-01-09 5 25 12 18.40 36.700 -49.86%
2021-01-02 5 25 12 17.40 25.940 -32.92%
2020-12-26 5 25 12 17.40 27.130 -35.86%
2020-12-19 5 25 12 17.40 20.100 -13.43%
2020-12-09 5 25 12 17.40 20.990 -17.1%
2020-12-07 5 23 12 15.60 21.500 -27.44%
2020-11-28 5 16 12 14.00 15.430 -9.27%
2020-11-03 5 16 12 14.00 12.710 10.15%
2020-10-09 5 17 7 13.20 NA NA%
2020-10-01 5 15 5 10.00 NA NA%
2020-09-22 5 11 5 6.80 NA NA%
2020-09-12 5 8 5 6.20 NA NA%
2020-08-17 4 8 5 6.00 NA NA%
2020-07-21 4 6 5 5.25 NA NA%
2020-06-29 4 6 5 5.25 NA NA%
2020-06-17 4 6 4 5.00 NA NA%
2020-05-07 4 6 4 5.00 NA NA%

PACB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.6 1 2 2 0 0 5

The Trend in the Broker Recommendations


Over the past 30 days, PACB's average broker recommendation rating improved by 0.3.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The variance in analysts' estimates of PACB is less than 12.63% of all US stocks.
  • PACB has a greater upside potential (average analyst target price relative to current price) than 90.35% of stocks in the mid market cap category.
  • PACB has a greater number of analysts covering the stock than 19.36% of stocks in the mid market cap category.
  • The average analyst price target of PACB is greater than 70.37% of Healthcare stocks.

Stocks similar to Pacific Biosciences Of California Inc in the Measuring and Control Equipment industry regarding analyst recommendations and price targets are RPID, AXDX and HTGM.

Is PACB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8593 seconds.